2020 CONGRESS
National Pharmaceutical Congress XIV
Day 1: October 21, 2020 - 11:00 A.M. - 12:30 P.M.
Day 2: October 28, 2020- 11:00 A.M. - 12:30 P.M.
Day 3: November 4, 2020- 11:00 A.M. - 12:30 P.M.
Resources
Day 1 Pre-Read
Agenda
Day 2 Pre-Read
Faculty Bios
Day 3 Pre-Read
Executive Summary
Session 1 Introduction
Mitch Shannon
Chronicle Companies
Session 1: Career Advice in a Post Covid World
Jim Hall
Senior Vice President and General Manager,
Covis Pharma Canada
Arima Ventin
Executive Director,
Market Access, Pricing and Government Relations,
Allergan (an AbbVie Company)
Brian Canestraro
General Manager,
Intercept Pharmaceuticals
​
Session 1 Live Panel Discussion
Tiana DiMichele
Director, Business Development,
Impres Inc.
Session 2 Introduction
Mitch Shannon
Chronicle Companies
Session 2: How Do We Launch Projects Post Covid-19?
Ross Glover
General Manager,
Taiho Pharma Canada Inc.
​
Pat Forsythe
General Manager,
Eisai Inc.
​
David Renwick
Vice President and General Manager,
Emergent BioSolutions
​
Session 2 Live Panel Discussion
Karl Frank
Divisional Director,
Bayshore Specialty Rx.
​
Session 3 Introduction
Ben Parry
Pangaea Consultants
Session 3: Industry Roles and Partnerships: Have They Changed Through Covid-19?
Pamela Fralick
President,
Innovative Medicines Canada
​
Andrew Casey
President and CEO,
BIOTECanada
​
Dr. Jason Field
President and CEO,
Life Sciences Ontario
​
Brian Bloom
Founder,
Bloom Burton & Co
​
Session 3 Live Panel Discussion
Tony Volpe
Senior Director,
Shoppers Drug Mart Specialty Health Network
​
Session 4 Introduction
Ben Parry
Pangaea Consultants
Session 4: Patient-Centricity: What Does It Mean in Action?
Carol Stiff
Head of Canada,
Santen Canada Inc.
​
​
Zal Press
Vice-Chair,
CADTH Patient and Community Advisory Committee
​
Peter Brenders
CEO,
New Brunswick Health Research Foundation
​
Session 4 Live Panel Discussion
Stephanie Babbitt
Senior Director,
McKesson Specialty Health
​
Session 5 Introduction
Ben Parry
Pangaea Consultants
Session 5: Future External Deployments, Structures and Skill Sets
Sylvie Pilon
Former Vice-President, General Manager,
Lundbeck Canada
​
Paul Petrelli
General Manager,
Jazz Pharmaceuticals Canada
​
Ronnie Miller
President and CEO,
Roche Canada
​
Session 5 Live Panel Discussion
James Cran
President,
Pharma Consultants Inc.
​
Session 6 Introduction
Mitch Shannon
Chronicle Companies
Session 6: Where Are We With Respect to Inclusion and Diversity?
Danielle Portnik
Product Manager,
Mallinckrodt Pharmaceuticals
Healthcare Businesswomen's Association Toronto President
​
Marissa Poole
Country Lead, Sanofi Canada
General Manager, Sanofi Genzyme Canada
​
Eileen McMahon
Partner,
Torys LLP
​
Session 6 Live Panel Discussion
Dave Cann
Senior Director, Business Development
Ashfield Healthcare Canada
​
Closing Remarks
Mitch Shannon
Chronicle Companies​